tiprankstipranks
Advertisement
Advertisement

PFE Stock Latest News

Pfizer’s Bevacizumab Biosimilar Safety Study in Japan Reaches Completion: What Investors Should Watch
Company AnnouncementsPfizer’s Bevacizumab Biosimilar Safety Study in Japan Reaches Completion: What Investors Should Watch
3h ago
PFE
Pfizer’s ODEN Study Update: Real-World Data on Tofacitinib in Ulcerative Colitis
PremiumCompany Announcements
Pfizer’s ODEN Study Update: Real-World Data on Tofacitinib in Ulcerative Colitis
3h ago
PFE
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
1d ago
AZN
BMY
Moderately bullish activity in Pfizer with shares down 2.08%
PremiumThe Fly
Moderately bullish activity in Pfizer with shares down 2.08%
2d ago
PFE
Analyst Maintains Hold on Pfizer, Keeps Price Target Unchanged at $27 Amid Pipeline Uncertainties
PremiumRatings
Analyst Maintains Hold on Pfizer, Keeps Price Target Unchanged at $27 Amid Pipeline Uncertainties
3d ago
PFE
Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri
PremiumThe FlyPfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri
3d ago
PFE
Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi
Premium
The Fly
Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi
3d ago
PFE
Pfizer Pivots to Obesity and Oncology as Wall Street Waits
Premium
Weekend Updates
Pfizer Pivots to Obesity and Oncology as Wall Street Waits
4d ago
PFE
Pfizer’s VESPER-4 Obesity Trial Signals a Serious Push Into the GLP-1 Growth Market
PremiumCompany Announcements
Pfizer’s VESPER-4 Obesity Trial Signals a Serious Push Into the GLP-1 Growth Market
5d ago
PFE
Pfizer’s Real-World Lung Cancer Study on Dacomitinib: What Investors Should Know
PremiumCompany Announcements
Pfizer’s Real-World Lung Cancer Study on Dacomitinib: What Investors Should Know
5d ago
PFE
Cboe data shows mixed options sentiment in Pfizer with shares down 0.44%
PremiumThe Fly
Cboe data shows mixed options sentiment in Pfizer with shares down 0.44%
5d ago
PFE
Pfizer announces seven-year follow-up results from Phase 3 CROWN trial
PremiumThe Fly
Pfizer announces seven-year follow-up results from Phase 3 CROWN trial
5d ago
PFE
Pfizer enters into global strategic collaboration with Innovent Biologics
PremiumThe FlyPfizer enters into global strategic collaboration with Innovent Biologics
6d ago
PFE
Pfizer’s New Phase 1 Trial Signals Steady Early-Stage Pipeline Progress
Premium
Company Announcements
Pfizer’s New Phase 1 Trial Signals Steady Early-Stage Pipeline Progress
6d ago
PFE
Cboe data shows mixed options sentiment in Pfizer with shareslittle changed
Premium
The Fly
Cboe data shows mixed options sentiment in Pfizer with shareslittle changed
6d ago
PFE
Guardant Health to present 38 abstracts at ASCO 2026 meeting
PremiumThe Fly
Guardant Health to present 38 abstracts at ASCO 2026 meeting
6d ago
GH
PFE
Pfizer Steps Up Obesity Push With New Phase 3 Berobenatide Trial
PremiumCompany Announcements
Pfizer Steps Up Obesity Push With New Phase 3 Berobenatide Trial
7d ago
PFE
Pfizer’s Next-Gen Infant Pneumococcal Vaccine Trial: What Investors Should Watch Now
PremiumCompany Announcements
Pfizer’s Next-Gen Infant Pneumococcal Vaccine Trial: What Investors Should Watch Now
7d ago
PFE
Moderately bullish activity in Pfizer with shares up 1.99%
PremiumThe Fly
Moderately bullish activity in Pfizer with shares up 1.99%
7d ago
PFE
Pfizer Kept at Hold as Oncology Catalyst Nears, Valuation Keeps Price Target Unchanged at $27
PremiumRatingsPfizer Kept at Hold as Oncology Catalyst Nears, Valuation Keeps Price Target Unchanged at $27
8d ago
PFE
Pfizer Juggles Trial Win, Setback and New Vaccine Bet
Premium
Weekend Updates
Pfizer Juggles Trial Win, Setback and New Vaccine Bet
11d ago
PFE
Citizens biotech analysts hold a dinnermeeting at ASCO
Premium
The Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
12d ago
AZN
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >